Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Alignment Healthcare (ALHC) Free Cash Flow (2020 - 2025)

Historic Free Cash Flow for Alignment Healthcare (ALHC) over the last 6 years, with Q3 2025 value amounting to $139.1 million.

  • Alignment Healthcare's Free Cash Flow rose 72234.77% to $139.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $150.6 million, marking a year-over-year increase of 18063.32%. This contributed to the annual value of -$6.6 million for FY2024, which is 9301.55% up from last year.
  • According to the latest figures from Q3 2025, Alignment Healthcare's Free Cash Flow is $139.1 million, which was up 72234.77% from $21.1 million recorded in Q2 2025.
  • Alignment Healthcare's Free Cash Flow's 5-year high stood at $139.1 million during Q3 2025, with a 5-year trough of -$198.1 million in Q4 2023.
  • Over the past 5 years, Alignment Healthcare's median Free Cash Flow value was $8.4 million (recorded in 2025), while the average stood at -$4.3 million.
  • As far as peak fluctuations go, Alignment Healthcare's Free Cash Flow plummeted by 46628.39% in 2022, and later surged by 72234.77% in 2025.
  • Alignment Healthcare's Free Cash Flow (Quarter) stood at -$30.1 million in 2021, then plummeted by 466.28% to -$170.6 million in 2022, then decreased by 16.07% to -$198.1 million in 2023, then soared by 90.91% to -$18.0 million in 2024, then surged by 872.76% to $139.1 million in 2025.
  • Its Free Cash Flow was $139.1 million in Q3 2025, compared to $21.1 million in Q2 2025 and $8.4 million in Q1 2025.